Mabion

Biotechnology accelerating the development of modern therapies

ABOUT THE PROJECT

Mabion S.A. is a Polish biotechnology company that helps develop and produce modern biological drugs. It operates in Konstantynów Łódzki, where it has advanced research and production facilities. The company supports its partners at every stage of drug development – from laboratory work and process development to production for clinical trials and sales. As a result, Mabion accelerates the development of innovative therapies and facilitates their introduction to the market.

WHAT NEEDS DOES THE INNOVATION ADDRESS?

Mabion is responding to the growing needs of the pharmaceutical and biotechnology market for the development and production of modern biological drugs, such as monoclonal antibodies, recombinant proteins, biosimilar drugs or vaccine components. These are some of the most advanced therapies in modern medicine, but their development and production require specialized knowledge, adequate infrastructure and the highest quality standards. Mabion provides pharmaceutical companies and biotech startups with access to these competencies without having to build their own costly production facilities. This allows innovative therapies to reach patients faster.

COMPETITIVE ADVANTAGES

Mabion offers a full range of services related to the development and production of biologic drugs – from cell line and process development to analytics and final GMP-compliant production. This shortens the time to deploy therapies and reduces costs.

The company has an advanced biotechnology complex and a team of experts, which allows it to carry out complex projects according to the highest quality and safety standards.

Cooperation with global partners and the implementation of projects related to the production of vaccine and drug components show that Mabion is successfully competing in the demanding biotechnology services market.

Learn more!